Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cymbalta neurology data

In a 12-week, double-blind study in 334 patients, Cymbalta reduced pain compared with placebo

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE